Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Aura Biosciences (AURA) Assets Average (2021 - 2026)

Aura Biosciences filings provide 6 years of Assets Average readings, the most recent being $153.6 million for Q1 2026.

  • Quarterly Assets Average fell 9.11% to $153.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $153.6 million through Mar 2026, down 9.11% year-over-year, with the annual reading at $176.0 million for FY2025, 19.57% down from the prior year.
  • Assets Average hit $153.6 million in Q1 2026 for Aura Biosciences, down from $179.7 million in the prior quarter.
  • Across five years, Assets Average topped out at $245.0 million in Q1 2024 and bottomed at $139.1 million in Q3 2022.
  • Average Assets Average over 5 years is $187.7 million, with a median of $186.3 million recorded in 2023.
  • The largest annual shift saw Assets Average skyrocketed 46.4% in 2022 before it tumbled 31.05% in 2025.
  • Aura Biosciences' Assets Average stood at $183.5 million in 2022, then rose by 18.46% to $217.4 million in 2023, then dropped by 10.81% to $193.9 million in 2024, then fell by 7.32% to $179.7 million in 2025, then fell by 14.56% to $153.6 million in 2026.
  • Per Business Quant, the three most recent readings for AURA's Assets Average are $153.6 million (Q1 2026), $179.7 million (Q4 2025), and $197.2 million (Q3 2025).